Cracking the code to beat addiction
We believe that healthcare should be affordable and accessible to all. At Lumme, we are making this a reality by designing technology that redefines what healthcare has to offer. We believe that ethically designed, patient-centric, comprehensively tested technology can solve healthcare’s leading problems.
Lumme is developing a cutting-edge addiction treatment platform by combining wearable technology, machine learning, and behavioral psychology. We are pushing the boundaries of digital health beyond activity monitoring by extracting actionable intelligence to offer deeper insights about health. Our mission is to deliver comprehensive solutions to the 200M individuals in our nation battling addiction with nicotine, alcohol, diet, marijuana, opioid, and other drugs.
Lumme is funded by multiple Small Business Innovation Research grants from the National Cancer Institute, National Institute of Alcohol Abuse and Alcoholism, and the National Institute of Diabetes and Digestive and Kidney Diseases. Years of research conducted at UMass Amherst and Yale School of Medicine has gone into designing this treatment platform.